Description
FINGOLIMOD, marketed under the brand name GILENYA, It is an prescription medication that has been approved fingolimod (Gilenya) on September 22, 2010. It was the first oral disease-modifying drug to be approved for the treatment of relapsing multiple sclerosis. The European Medicines Agency approved fingolimod for use in the European Union in March 2011
What is Gilenya (Fingolimod) ?
Gilenya (fingolimod) is a sphingosine 1-phosphate receptor modulator indicated for the treatment of patients with relapsing forms of multiple sclerosis. Gilenya® (fingolimod) is an oral disease-modifying therapy (DMT) that is highly efficacious at controlling disease activity in relapsing multiple sclerosis (RMS). Gilenya has a reversible lymphocyte redistribution effect targeting both focal and diffuse central nervous system (CNS) damage caused by MS. Long-term clinical trial and real-world evidence and experience has shown Gilenya treatment to be convenient for individuals to incorporate into everyday life, leading to high treatment satisfaction, long-term persistence, and ultimately, improved long-term outcomes for people with RMS.
How to order approved “Gilenya (Fingolimod) for Capsules” Medicine?
GILENYA (FINGOLIMOD) Capsules is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing GILENYA and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.
